Miura Tomoaki, Kanemoto Kenichi, Natsume Satomi, Atsumi Kunio, Fushimi Hideki, Yoshida Takuji, Ajito Keiichi
Pharmaceutical Research Center, Meiji Seika Kaisha, Ltd, 760 Morooka-cho, Kohoku-ku, Yokohama 222-8567, Japan.
Bioorg Med Chem. 2008 Dec 1;16(23):10129-56. doi: 10.1016/j.bmc.2008.09.054. Epub 2008 Sep 25.
The design and synthesis of novel 14- to 16-membered 11-azalides starting from 16-membered macrolides are reported. A linear 9-formylcarboxylic acid was isolated via a mobile dialdehyde previously reported. Sequential macrocyclization of the formylcarboxylic acid with amino alcohol followed by deprotection afforded corresponding 14- to 16-membered azalides. On the other hand, reductive amination of the formylcarboxylic acid with an azidoamine followed by macrolactam formation with an amine generated from the azide gave 14- to 16-membered azalactams. Among these derivatives, 15-membered azalactams and 16-membered azalides exhibited characteristic in vitro antibacterial activities. Although optimization of 15-membered azalactams including demycarosyl analogues did not provide remarkably promising molecules, SAR studies of 16-membered azalides disclosed that substitution at the 15 position was very important for identification of a clinical candidate.
报道了从16元大环内酯类化合物出发设计合成新型14至16元11-氮杂内酯的方法。通过先前报道的可移动二醛分离得到线性9-甲酰基羧酸。甲酰基羧酸与氨基醇依次进行大环化反应,随后脱保护得到相应的14至16元氮杂内酯。另一方面,甲酰基羧酸与叠氮胺进行还原胺化反应,随后与叠氮化物生成的胺形成大环内酰胺,得到14至16元氮杂内酰胺。在这些衍生物中,15元氮杂内酰胺和16元氮杂内酯表现出特征性的体外抗菌活性。尽管对包括去碳霉糖基类似物在内的15元氮杂内酰胺进行优化未能得到非常有前景的分子,但对16元氮杂内酯的构效关系研究表明,15位的取代对于确定临床候选药物非常重要。